BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK) investors concerning the Company and its officers’ possible violations of federal securities laws.
On December 18, 2019, Seligman Research published a report alleging that the Company, among other issues, “buried the results for the two AK001 studies it conducted,” has “a checkered history of conducting small, low-credibility trials, marked by . . . discrepancies, omissions, cherry-picking, and other red flags,” and engaged in “[f]lagrant nepotism in key clinical roles.”
On this news, the Company’s stock price fell $13.25, or nearly 10%, to close at $119.28 per share on December 18, 2019, thereby injuring investors.
If you purchased Allakos securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.